"Waitlist mortality" is high for myeloma patients with limited access to BCMA therapy
对于难以获得BCMA疗法的多发性骨髓瘤患者而言，“等待名单死亡率”很高。
期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1206715
Ahmed, Nausheen; Wesson, William; Mushtaq, Muhammad Umair; Bansal, Rajat; AbdelHakim, Haitham; Bromert, Sarah; Appenfeller, Allison; Ghazal, Batool Abu; Singh, Anurag; Abhyankar, Sunil; Ganguly, Siddhartha; McGuirk, Joseph; Abdallah, Al-Ola; Shune, Leyla
